Tomlinson Lab

Gail Tomlinson, MD, PhD

Rank: Professor
Department: Pediatrics
Division: Chief of Hematology-Oncology
Office: 4.100.20
Tel: 210-562-9116
Office: 210-567-7477
tomlinsong@uthscsa.edu
Pediatric Hematology-Oncology Website

Dr. Gail Tomlinson, MD, PhD, joined UT Health San Antonio in 2007 as the Division Chief of Pediatric Hematology-Oncology and currently also serves at the Mays Cancer Center as co-leader of the Population Science and Prevention Program. Since her arrival, Dr. Tomlinson has also served as Interim Director of the GCCRI and Interim Chair of the Department of Pediatrics.

Dr. Tomlinson received her MD from George Washington University School of Medicine and her PhD in Biochemistry from Duke University. She completed an internship and residency at the Children’s National Medical Center in Washington, D.C.. She completed a research fellowship in cancer genetics at the University of Texas MD Anderson Cancer Center in Houston, followed by a formal fellowship in pediatric hematology-oncology at the University of Texas Southwestern Medical Center in Dallas. Dr. Tomlinson was a faculty member at the University of Texas Southwestern Medical Center from 1992 to 2006, where he was a tenured Associate Professor and held the Children’s Cancer Fund Distinguished Professorship in Pediatric Oncology Research. She is currently the holder of the Greehey Distinguished Chair in Cancer and Genetics.

Dr. Tomlinson is board-certified in pediatrics and pediatric hematology-oncology. Her research interests are in the genetic origins of childhood cancers, particularly tumors of the liver. She leads a multi-site program working with cancer-prone individuals and families throughout South Texas. She has also initiated an investigation of predisposing factors underlying the increased incidence of leukemia in children of Hispanic background in South Texas.

Dr. Tomlinson has served on multiple national and state committees focusing on advancing research, education, and advocacy in cancer, including the Cancer Prevention and Research Institute’s Advisory Committee for Childhood Cancer, the Children’s Oncology Group Rare Tumors Committee, and the National Cancer Institute’s Board of Scientific Counselors.  She currently serves on several NIH and other research review panels.  She has published over 200 scientific papers.